ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability

NCT04561245 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Nonalcoholic Steatohepatitis

Interventions

DRUG: ALT-801
OTHER: Placebo

Sponsor

Altimmune, Inc.